Immunisation against Chlamydia trachomatis
AssigneeNovartis Vaccines and Diagnostics, Inc.
InventorsGuido Grandi, Giulio Ratti
Life of this patent
Estimating the term…
Abstract
The present invention provides antigenic proteins of Chlamydia trachomatis. The proteins of the present invention are useful for eliciting an immune response to Chlamydia in a patient. For example, an effective amount of protein of the present invention or fraction thereof may be administered to a patient for eliciting a Chlamydia specific immune response. In another example, a method of raising an antibody specific for Chlamydia trchomatis elementary bodies (EB) is provided in which a protein of the present invention is administered to a patient.
Claims12
A method of eliciting a Chlamydia specific immune response in a patient, the method comprising the step of administering to the patient an effective amount of a protein comprising an amino acid sequence having at least 70% identity to SEQ ID NO:
- 255.
A method of raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) comprising the step of administering to a patient a protein comprising an amino acid sequence having at least 70% identity to SEQ ID NO:
- 255.
Dependencies are inferred from the claim text.